ARCHIVES

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

ACCP Publishes Guidelines Recommending Low-Dose CT

May 31, 2013

Phase III Avastin Trial Fails Primary Endpoints

February 28, 2014

Patient Advocates Ask HCFA To Clarify Coverage Decision.

September 8, 2000

ORI Misconduct Findings Announced In Two Cases

July 12, 1996

In Brief: Ruddon To Head Eppley Institute; Shapiro elected ACR President; ACR Medalists Named

November 3, 1989

NCI Gets 41.258 Bil. In Final FY 1986 Appropriations

November 29, 1985